BioNexus Gene Lab Corp ($BGLC), Fidelion, and Tongshu Gene, Patent Support Signing
The CEO of BioNexus Gene Lab Corp. (Nasdaq: BGLC), Sam Tan with the CEO of Tongshu Gene, Dr. Yan Linghua, together with the BGLC and Fidelion Team during the signing of a Patent Support Agreement for the development of new, upgraded Patents & Global IP.
Format
PNG
Source
BioNexus Gene Lab Corp.